<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Point-of-care</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Abbott’s $5 COVID-19 rapid test wins FDA emergency use nod</title>
      <description>
        <![CDATA[The U.S. FDA has cleared the way for Abbott Laboratories sixth COVID-19 test, a near-patient, point-of-care antigen test that gives results in 15 minutes and can be run without laboratory equipment. The company has priced the Binaxnow COVID-19 Ag Card rapid test at $5 and is offering a complementary mobile app that allows people to display their test results when asked by organizations for verification.]]>
      </description>
      <guid>http://www.bioworld.com/articles/497099</guid>
      <pubDate>Thu, 27 Aug 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/497099-abbotts-5-covid-19-rapid-test-wins-fda-emergency-use-nod</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/8-26-Abbott_BinaxNow_kit.webp?t=1598566225" type="image/png" medium="image" fileSize="1129046">
        <media:title type="plain">8-26-Abbott_BinaxNow_kit</media:title>
        <media:description type="plain">Abbott’s BinaxNOW test</media:description>
      </media:content>
    </item>
    <item>
      <title>FDA lays out top priorities for COVID-19 testing, weighs in on asymptomatic screening</title>
      <description>
        <![CDATA[The U.S. FDA detailed which kinds of SARS-CoV-2 tests are getting top priority, with access to rolling, rapid reviews for emergency use authorization (EUA) during the unfolding pandemic. The agency is aiming to authorize point-of-care and at-home tests to better distribute the use of testing in various locations. It also is looking at automated and high-throughput tests that can offer analysis of larger batches of tests at one time.]]>
      </description>
      <guid>http://www.bioworld.com/articles/435878</guid>
      <pubDate>Wed, 17 Jun 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435878-fda-lays-out-top-priorities-for-covid-19-testing-weighs-in-on-asymptomatic-screening</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/Regulatory-US-FDA-HQ.webp?t=1707859292" type="image/png" medium="image" fileSize="2264756">
        <media:title type="plain">U.S. FDA headquarters</media:title>
      </media:content>
    </item>
    <item>
      <title>Centrifugation can be child’s play with fidget spinners</title>
      <description>
        <![CDATA[Fidget spinners are hand-held toys based on a roller bearing and three weighted lobes, which can spin freely, creating centrifugal force when activated manually.]]>
      </description>
      <guid>http://www.bioworld.com/articles/435514</guid>
      <pubDate>Tue, 02 Jun 2020 15:34:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435514-centrifugation-can-be-childs-play-with-fidget-spinners</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/May-2020/Fidget-spinner-5-28.webp?t=1590687647" type="image/png" medium="image" fileSize="215968">
        <media:title type="plain">Fidget spinner toy and diagnostic fidget spinner</media:title>
        <media:description type="plain">A. Photos of a fidget spinner toy (left) and a diagnostic
fidget spinner (right). B. Bacterial load detection by color changes.
Orange color shows high bacterial cell load.
Credit: Institute for Basic Science (IBS, South Korea)</media:description>
      </media:content>
    </item>
    <item>
      <title>Memed secures CE mark for new POC blood test</title>
      <description>
        <![CDATA[LONDON &ndash; After eight years in development, Memed Diagnostics Ltd. has secured CE marking for its point-of-care blood test, which is able to distinguish between bacterial and viral infections in 15 minutes.]]>
      </description>
      <guid>http://www.bioworld.com/articles/435519</guid>
      <pubDate>Tue, 02 Jun 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435519-memed-secures-ce-mark-for-new-poc-blood-test</link>
    </item>
    <item>
      <title>Centrifugation can be child’s play with fidget spinners</title>
      <description>
        <![CDATA[Fidget spinners are hand-held toys based on a roller bearing and three weighted lobes, which can spin freely, creating centrifugal force when activated manually. Generating centrifugal force with a fidget spinner takes neither electricity nor trained staff. And that has suggested to several researchers that such spinners, under the right circumstances, could be used for centrifugation under circumstances where reliably operating a centrifuge, for  whatever reason, is a challenge.]]>
      </description>
      <guid>http://www.bioworld.com/articles/435398</guid>
      <pubDate>Thu, 28 May 2020 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435398-centrifugation-can-be-childs-play-with-fidget-spinners</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/May-2020/Fidget-spinner-5-28.webp?t=1590687647" type="image/png" medium="image" fileSize="215968">
        <media:title type="plain">Fidget spinner toy and diagnostic fidget spinner</media:title>
        <media:description type="plain">A. Photos of a fidget spinner toy (left) and a diagnostic
fidget spinner (right). B. Bacterial load detection by color changes.
Orange color shows high bacterial cell load.
Credit: Institute for Basic Science (IBS, South Korea)</media:description>
      </media:content>
    </item>
    <item>
      <title>Astrotech enters COVID-19 fight with screening instrument for lung diseases</title>
      <description>
        <![CDATA[Astrotech Corp., of Austin, Texas, has a broad range, having developed mass spectrometers in agriculture and manufacturing and selling chemical analyzers for use in the airport security and other applications. Now, it is looking to help in the fight against COVID-19.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433963</guid>
      <pubDate>Wed, 25 Mar 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/433963-astrotech-enters-covid-19-fight-with-screening-instrument-for-lung-diseases</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Infectious/respiratory-lung-COVID-19-coronavirus.webp?t=1745261670" type="image/jpeg" medium="image" fileSize="595261">
        <media:title type="plain">Respiratory infection</media:title>
      </media:content>
    </item>
    <item>
      <title>Bedside MRI system receives green light from the FDA</title>
      <description>
        <![CDATA[Guilford, Conn.-based Hyperfine Research Inc. has received the U.S. FDA&rsquo;s nod for a bedside magnetic resonance imaging (MRI) system and is eyeing this summer for shipments. The portable system can be wheeled directly to the patient&rsquo;s bedside and plugs into a standard electrical wall outlet.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433039</guid>
      <pubDate>Wed, 12 Feb 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/433039-bedside-mri-system-receives-green-light-from-the-fda</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/2-12-hyperfine-MRI.webp?t=1581548138" type="image/png" medium="image" fileSize="624458">
        <media:title type="plain">2-12-hyperfine-MRI.png</media:title>
        <media:description type="plain">Portable MRI system. Credit: Hyperfine Research Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>FDA gives green light to software that helps in the acquisition of cardiac ultrasound images</title>
      <description>
        <![CDATA[Brisbane, Calif.-based Caption Health Inc. received good news from the U.S. FDA, which has given a thumbs up to Caption Guidance. This software aims to assist medical professionals in the acquisition of cardiac ultrasound images and uses artificial intelligence (AI) to provide real-time guidance. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/432973</guid>
      <pubDate>Mon, 10 Feb 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/432973-fda-gives-green-light-to-software-that-helps-in-the-acquisition-of-cardiac-ultrasound-images</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/2-10-Caption-Health-ultrasound.webp?t=1581372434" type="image/png" medium="image" fileSize="402663">
        <media:title type="plain">2-10-Caption-Health-ultrasound.png</media:title>
        <media:description type="plain">Caption Guidance. Credit: Caption Health Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Lumos Diagnostics scoops up $15M in series A to back Febridx test</title>
      <description>
        <![CDATA[With an eye toward expanding the reach of its Febridx rapid point-of-care (POC) test, Lumos Diagnostics Holdings Pty. Ltd. has seen the closing of a $15 million series A round from Australia&rsquo;s Planet Innovation. The funds will back a U.S. FDA pivotal clinical trial, as well as additional development and manufacturing resources for the company&rsquo;s expanding full-service POC business.]]>
      </description>
      <guid>http://www.bioworld.com/articles/432880</guid>
      <pubDate>Wed, 05 Feb 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/432880-lumos-diagnostics-scoops-up-15m-in-series-a-to-back-febridx-test</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/2-5-Lumos-Febridx.webp?t=1580941669" type="image/png" medium="image" fileSize="348630">
        <media:title type="plain">2-5-Lumos-Febridx.png</media:title>
        <media:description type="plain">Febridx test. Credit: Lumos Diagnostics</media:description>
      </media:content>
    </item>
    <item>
      <title>Wyss Institute researchers develop hand-held rapid diagnostics technology</title>
      <description>
        <![CDATA[Hand-held diagnostics don&#39;t come cheaply, and their applications remain somewhat limited. Abbott Laboratories&#39; Istat portable clinical analyzer, for example, retails at about $15,000, with each individual cartridge costing hundreds of dollars apiece to measure each of roughly a few dozen blood gas, electrolyte, chemistry and hematology levels in few minutes from two to three drops of whole blood.]]>
      </description>
      <guid>http://www.bioworld.com/articles/431166</guid>
      <pubDate>Fri, 15 Nov 2019 02:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/431166-wyss-institute-researchers-develop-hand-held-rapid-diagnostics-technology</link>
    </item>
  </channel>
</rss>
